Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J R Foster

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|November 17, 2010
CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualization in H. pylori eradicationMichael B Ward, David J R Foster
Paediatric Anaesthesia|August 24, 2016
An introduction to physiologically-based pharmacokinetic modelsRichard N Upton, David J R Foster, Ahmad Y Abuhelwa
Journal of Pharmacological and Toxicological Methods|April 6, 2015
ADVAN-style analytical solutions for common pharmacokinetic modelsAhmad Y Abuhelwa, David J R Foster, Richard N Upton
The AAPS Journal|August 7, 2016
A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pHAhmad Y Abuhelwa, David J R Foster, Richard N Upton
The AAPS Journal|July 22, 2016
A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit TimeAhmad Y Abuhelwa, David J R Foster, Richard N Upton
British Journal of Clinical Pharmacology|February 21, 2006
Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioidsGlynn A Morrish, David J R Foster, Andrew A Somogyi
Journal of Pharmacokinetics and Pharmacodynamics|February 15, 2017
Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrationsJim H Hughes, Richard N Upton, David J R Foster
Clinical and Experimental Pharmacology & Physiology|April 19, 2007
The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heartDeyi Xu, Shuangjie Zhang, David J R Foster, et al.
Drugs in R&D|January 12, 2017
Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion MethodMaryam Bazargan, David J R Foster, Andrew K Davey, et al.
British Journal of Clinical Pharmacology|May 21, 2004
Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patientsDavid J R Foster, Andrew A Somogyi, Jason M White, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|November 17, 2010
CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualization in H. pylori eradicationMichael B Ward, David J R Foster
Paediatric Anaesthesia|August 24, 2016
An introduction to physiologically-based pharmacokinetic modelsRichard N Upton, David J R Foster, Ahmad Y Abuhelwa
Journal of Pharmacological and Toxicological Methods|April 6, 2015
ADVAN-style analytical solutions for common pharmacokinetic modelsAhmad Y Abuhelwa, David J R Foster, Richard N Upton
The AAPS Journal|August 7, 2016
A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pHAhmad Y Abuhelwa, David J R Foster, Richard N Upton
The AAPS Journal|July 22, 2016
A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit TimeAhmad Y Abuhelwa, David J R Foster, Richard N Upton
British Journal of Clinical Pharmacology|February 21, 2006
Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioidsGlynn A Morrish, David J R Foster, Andrew A Somogyi
Journal of Pharmacokinetics and Pharmacodynamics|February 15, 2017
Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrationsJim H Hughes, Richard N Upton, David J R Foster
Clinical and Experimental Pharmacology & Physiology|April 19, 2007
The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heartDeyi Xu, Shuangjie Zhang, David J R Foster, et al.
Drugs in R&D|January 12, 2017
Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion MethodMaryam Bazargan, David J R Foster, Andrew K Davey, et al.
British Journal of Clinical Pharmacology|May 21, 2004
Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patientsDavid J R Foster, Andrew A Somogyi, Jason M White, et al.
Pageof 6